A Case of Staphylococcal Scalded Skin Syndrome in a 1-Year Old Boy with Otitis Media

Abstract

Introduction: Staphylococcal scalded skin syndrome (SSSS), also known as Ritter’s Disease, is a severe disease seen mostly in newborns and children aged <5 years, and the mortality rate might reach to 4% despite an appropriate treatment. Exfoliative toxins cause intraepidermal separation in the stratum granulosum and lead to a condition that is characterized with widespread epidermolysis all over the body and bullae with positive Nikolsky’s sign. SSSS might be fatal due to loss of skin barrier. Immediate initiation of an anti-staphylococcal drug therapy is required for the treatment of this toxin-dependent disease, which is one of the emergencies of dermatology practices.Case Report: A 1-year-old boy was referred to a dermatology clinic from pediatric emergency service with widespread epidermolysis all over the body, including erosion and bullous formation that had been appeared in the inguinal region. SSSS was suspected in this case, and skin biopsy was performed to confirm the diagnosis. He was hospitalized in the Pediatric Infectious Diseases Service, and treatment comprising intravenous administration of (i.v.) vancomycin (40 mg/kg/day) and 3 gIVIG ( intravenous immunoglobulin) was initiated.Conclusion: Staphylococcus aureus, a rather rare agent of otitis media, is remarkable in terms of causing the complication of SSSS, which is very rare. In our case report, we aimed to remark to this rare condition (association of otitis media and SSSS)

Keywords

• Staphylococcal scalded skin syndrome, Staphylococcus aureus, otitis media

References

1. Handler MZ, Schwartz RA. Staphylococcalscalded skin syndrome: diag- nosisandmanagement in childrenandadults. J Eur Acad Dermatol Vene- reol 2014; 28: 1418-23. [CrossRef]
2. Lyell A. Toxicepidermalnecrolysis: An eruptionresemblingscalding of the skin. Br J Dermatol 1956; 68: 355-61. [CrossRef]
3. Jenkins A, Diep BA, Mai TT, Vo NH, Warrener P, Suzich J, et al. Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease. MBio 2015; 6: e02272-14. [CrossRef]
4. Loughead JL. Congenitalstaphylococcalscalded skin syndrome: Report of a case. Pediatr Infect Dis J 1992; 11: 413-4. [CrossRef]
5. Neff MJ; American Academy of Pediatrics; American Academy of Fami- lyPhysicians. AAP, AAFP releaseguideline on diagnosisandmanagement of acuteotitismedia. Am Fam Physician 2004; 69: 2713-5. [CrossRef]
6. Amagai M. Desmoglein as a target in autoimmunity and infection. J Am Acad Dermatol 2003; 48: 244-52.
7. Blyth M, Estela C, Young AE. Severe staphylococcalscalded skin syn- drome in children. Burns 2008; 34: 98-103. [CrossRef]
8. Hawkey PM. Thegrowing burden of antimicrobial resistance. J Antimi- crob Chemother 2008; 62(Suppl 1): i1-9. [CrossRef]

9. Stryjewski ME, Corey GR. New treatments for methicillin-resistant Staphylococcus aureus. Curr Opin Crit Care 2009; 15: 403-12. [CrossRef]
10. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitoryconcentration on thet- reatment of methicillin-resistantStaphylococcusaureusbacteremia. Clin Infect Dis 2008; 46: 193-200.